Head and Neck Cancer Clinical Trial
Official title:
Evaluation of Diagnostic Aids for Detection and Diagnosis of Oral Cancer
The goal of this clinical study is to find out if certain instruments/devices, such as wide field fluorescence imaging point spectroscopy and/or brush cytology, can help health care providers find mouth cancer more quickly than a standard oral clinical exam.
Study Procedures:
Certain types of light may cause cells to give off a tiny amount of light (called
fluorescence). Researchers have learned that cancer cells and normal cells reflect light and
give off fluorescence differently. Researchers want to find out if different kinds of light
can be used to discover areas of the mouth that may have abnormal or cancerous cells.
If you agree to take part in this study, a researcher may use up to 3 types of imaging
instruments to take pictures and readings of several areas in your mouth.
- VELScope is an FDA approved handheld camera device that takes images of the mouth with
different colors of light. The VELScope shines blue light into the mouth, and pictures
are taken using a camera that is attached to the device.
- Widefield Fluorescence Imaging uses a non-contact imaging device similar to the
VELScope. It shines different colors of light and then takes pictures of the inside of
the mouth using a digital camera.
- Point Spectroscopy System uses a probe (about the size of a tip of a pen) that is
gently placed on several areas of the mouth. Different colors of light are directed
through optic fibers to the lining of the mouth, and the probe collects the light that
returns from the tissue and sends the information to a computer.
Researchers will record whether the doctors find any areas within your mouth that may not
appear completely normal. They will collect tissue samples of these abnormal areas using a
brush biopsy. To perform an oral brush biopsy, the research will press a small brush against
an area inside your mouth, and turn it 5-10 times. The areas that could be biopsied include
your gums, tongue, the roof of your mouth, the bottom of your mouth, or the inside of your
cheeks. Any cells collected from the inside of your mouth will be placed on slides to be
studied by the study team.
The samples being collected will only be used for this testing, and no leftover samples will
be kept by the research staff.
These procedures should take about 20 minutes total.
This is an investigational study. The VELScope is an FDA approved device and is commercially
available. Wide-field and point spectroscopy systems are not FDA approved and are only
authorized for research. Up to 500 participants will take part in this multicenter study. Up
to 250 will be enrolled at MD Anderson.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05808920 -
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
|
||
Completed |
NCT02526017 -
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
|
Phase 1 | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03997643 -
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04700475 -
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
|
N/A | |
Withdrawn |
NCT04058145 -
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02572869 -
Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
|
||
Active, not recruiting |
NCT04474470 -
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05073809 -
Photoacoustic Imaging of Head and Neck Tumours
|
||
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03651570 -
Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study
|
N/A | |
Recruiting |
NCT04930432 -
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Terminated |
NCT03843554 -
Commensal Oral Microbiota in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05915572 -
Mulligan Technique on Shoulder Dysfunction
|
N/A | |
Completed |
NCT05897983 -
Tens and Rocabado Exercises on TMJ Dysfunction
|
N/A | |
Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
Withdrawn |
NCT05263648 -
Virtual Reality Software to Reduce Stress in Cancer Patients
|
N/A | |
Withdrawn |
NCT03238638 -
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
|
Phase 2 |